BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3923527)

  • 41. [Attention deficit-hyperactivity disorder (ADHD); etiology, diagnosis and treatment].
    't Jong GW; van den Anker JN
    Ned Tijdschr Geneeskd; 2000 Nov; 144(46):2227-8. PubMed ID: 11103263
    [No Abstract]   [Full Text] [Related]  

  • 42. [Neuropsychological assessment of the effectiveness of OROS-methylphenidate in attention deficit hyperactivity disorder].
    Rubio-Morell B; Martín-González R; Herreros-Rodríguez O; González-Pérez P; Hernández-Exposito S; Quintero-Fuentes I; Gracia-Marco R
    Rev Neurol; 2008 May 16-31; 46(10):602-8. PubMed ID: 18465700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An open trial of pargyline in the treatment of attention deficit disorder, residual type.
    Wender PH; Wood DR; Reimherr FW; Ward M
    Psychiatry Res; 1983 Aug; 9(4):329-36. PubMed ID: 6359210
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attention deficit disorder ('minimal brain dysfunction') in adults. A replication study of diagnosis and drug treatment.
    Wender PH; Reimherr FW; Wood DR
    Arch Gen Psychiatry; 1981 Apr; 38(4):449-56. PubMed ID: 7011250
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Psychological assessment of children with minimal brain dysfunction.
    Conners CK
    Ann N Y Acad Sci; 1973 Feb; 205():283-302. PubMed ID: 4570234
    [No Abstract]   [Full Text] [Related]  

  • 46. Treatment of chronic cocaine abuse and attention deficit disorder, residual type, with magnesium pemoline.
    Weiss RD; Pope HG; Mirin SM
    Drug Alcohol Depend; 1985 May; 15(1-2):69-72. PubMed ID: 4017880
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Substituting stimulants in treating behavior disorders.
    El-Defrawi MH; Greenhill LL
    Am J Psychiatry; 1984 Apr; 141(4):610. PubMed ID: 6703148
    [No Abstract]   [Full Text] [Related]  

  • 48. Attention deficit disorder in adolescents.
    Silver LB; Brunstetter RW
    Hosp Community Psychiatry; 1986 Jun; 37(6):608-13. PubMed ID: 3721420
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Propranolol for adults with temper outbursts and residual attention deficit disorder.
    Mattes JA
    J Clin Psychopharmacol; 1986 Oct; 6(5):299-302. PubMed ID: 3771813
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The so-called "persistent infantile pattern of attentiveness" in minimal brain dysfunction children. Essay of a human ethologic interpretation with its consequences in therapy (author's transl].
    Wolfenberger-Haessig C
    Ther Umsch; 1977 Jan; 34(1):15-20. PubMed ID: 841504
    [No Abstract]   [Full Text] [Related]  

  • 51. Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report.
    Wood DR; Reimherr FW; Wender PH; Johnson GE
    Arch Gen Psychiatry; 1976 Dec; 33(12):1453-60. PubMed ID: 793563
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pemoline in attention deficit disorder and alcoholism: a case study.
    Turnquist K; Frances R; Rosenfeld W; Mobarak A
    Am J Psychiatry; 1983 May; 140(5):622-4. PubMed ID: 6303137
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Attention deficit hyperactivity disorder: does it affect adults too?
    Heath CT; Wright HH; Batey SR
    South Med J; 1990 Dec; 83(12):1396-401. PubMed ID: 2251528
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Catecholamine metabolism in the attention deficit disorder: implications for the use of amino acid precursor therapy.
    McConnell H
    Med Hypotheses; 1985 Aug; 17(4):305-11. PubMed ID: 4046902
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hallucinations during methylphenidate therapy.
    Gross-Tsur V; Joseph A; Shalev RS
    Neurology; 2004 Aug; 63(4):753-4. PubMed ID: 15326264
    [No Abstract]   [Full Text] [Related]  

  • 56. Attention deficit hyperactivity in adults.
    Cubbin S; Leahy A
    Br J Psychiatry; 1998 Apr; 172():366. PubMed ID: 9715347
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinical picture, diagnosis and treatment possibilities of minimal brain dysfunction].
    Peters H; Vogt HJ
    Offentl Gesundheitswes; 1988; 50(8-9):480-4. PubMed ID: 2972964
    [No Abstract]   [Full Text] [Related]  

  • 58. Magnesium pemoline and dextroamphetamine: a controlled study in children with minimal brain dysfunction.
    Conners CK; Taylor E; Meo G; Kurtz MA; Fournier M
    Psychopharmacologia; 1972; 26(4):321-36. PubMed ID: 4508756
    [No Abstract]   [Full Text] [Related]  

  • 59. Adult minimal brain dysfunction and schizophrenia: a case report.
    Huey LY; Zetin M; Janowsky DS; Judd LL
    Am J Psychiatry; 1978 Dec; 135(12):1563-5. PubMed ID: 717582
    [No Abstract]   [Full Text] [Related]  

  • 60. Unexpected consequence of treatment for attention deficit disorder.
    Merrill RD; Garfinkel B
    Am J Psychiatry; 1987 Feb; 144(2):250. PubMed ID: 3492932
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.